Suppr超能文献

应用 CyberKnife 治疗局限性脉络膜血管瘤:一种可行的选择。

Treatment of circumscribed choroidal hemangioma using CyberKnife: A viable alternative.

机构信息

Shree Bhagwan Mahavir Vitreoretinal Services Department, Sankara Nethralaya, College Road, Nungambakkam, Tamil Nadu, India.

Department of Radiation Oncology and Cyberknife Services, Apollo Hospitals, Teynampet, Chennai, Tamil Nadu, India.

出版信息

Indian J Ophthalmol. 2019 May;67(5):704-706. doi: 10.4103/ijo.IJO_1410_18.

Abstract

Circumscribed choroidal hemangioma is a benign vascular hamartoma without systemic associations. For symptomatic cases, treatment options are photodynamic therapy (PDT), transpupillary thermotherapy (TTT), intravitreal injection of anti-vascular endothelial growth factor (VEGF), or radiation therapy. CyberKnife radiosurgery is an image-guided radiation therapy that delivers radiation to lesions anywhere in the body with an accuracy of 0.5 mm without damage to surrounding structures. We report a case of circumscribed choroidal hemangioma which was successfully treated with CyberKnife therapy. The literature search reveals cases of uveal melanoma, intraocular, and periocular lymphoma successfully treated with CyberKnife therapy. To the best of our knowledge, this is the first report on such treatment for choroidal hemangioma.

摘要

局限性脉络膜血管瘤是一种良性血管错构瘤,无全身相关疾病。对于有症状的病例,治疗方法包括光动力疗法(PDT)、经瞳孔温热疗法(TTT)、眼内注射抗血管内皮生长因子(VEGF)或放射治疗。CyberKnife 放射外科是一种图像引导的放射治疗,它可以将辐射精确地输送到身体任何部位的病变处,精度为 0.5 毫米,不会对周围结构造成损害。我们报告了一例局限性脉络膜血管瘤,成功地接受了 CyberKnife 治疗。文献检索显示,CyberKnife 治疗成功的病例包括葡萄膜黑色素瘤、眼内和眼周淋巴瘤。据我们所知,这是首例关于 CyberKnife 治疗脉络膜血管瘤的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fb/6498904/5c874e5b051e/IJO-67-704-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验